Advertisement

Imaging in Inflammatory Carcinoma

  • Yolanda Villaseñor-Navarro
  • Lesvia Olivia Aguilar-Cortazar
  • Irma Perez-Zuñiga
  • Roberto Alejandro Cruz-Morales
  • Cecilia Magdalena Pavon-Hernandez
  • Martha Patricia Perez-Badillo
  • Jaime Ignacio Garcia-Gomez
Chapter

Abstract

Inflammatory carcinoma is a rare and aggressive form of primary epithelial cancer that includes 1–6 % of breast cancer and is associated to a poor prognosis given the high probability of micrometastases at diagnosis; about 20 % of patients have distant metastases at diagnosis [1], with a high incidence of recurrence, higher than those noninflammatory carcinoma.

Inflammatory breast cancer is diagnosed clinically by the rapid appearance of erythema and edema called “orange peel” involving at least one third of the skin around the breast. In this chapter, it discusses the various methods of imaging and its usefulness in the diagnosis of inflammatory breast cancer.

Keywords

Positron Emission Tomography Inflammatory Breast Cancer Internal Mammary Chain Positron Emission Mammography Granulomatous Mastitis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Yang WT, Le-Petross HT, Macapinlac H, et al. Inflammatory breast cancer: PET/CT, MRI, mammography, and sonography findings. Breast Cancer Res Treat. 2008;109:417–26.PubMedCrossRefGoogle Scholar
  2. 2.
    Edge SB, Byrd DR, Compton CC, et al. AJCC cancer staging manual. 7th ed. New York: Springer; 2010.Google Scholar
  3. 3.
    Bonnier P, Charpin C, et al. Inflammatory carcinomas of the breast a clinical, pathological, or a clinical and pathological definition? Int J Cancer. 1995;62:382–5.PubMedCrossRefGoogle Scholar
  4. 4.
    Le-Petross H, Uppendahl L, Stafford J. Sonographic features of inflammatory breast cancer. Semin Roentgenol. 2011;46(4):275–9.PubMedCrossRefGoogle Scholar
  5. 5.
    Haagensen C. Diseases of the breast. 2ath ed. Philadelphia: Pasauder; 1971. p. 569–84.Google Scholar
  6. 6.
    Kim T, Lau J, Erban J. Lack of uniform diagnostic criteria for inflammatory breast cancer limits interpretation of treatment outcomes: a systematic review. Clin Breast Cancer. 2006;7:386–95. CrossRefMedlineWeb of Science.PubMedCrossRefGoogle Scholar
  7. 7.
    Kushwaha AC, Whitman GJ, Stelling CB, Cristofanilli MC, Buzdar AU. Primary inflammatory carcinoma of the breast: retrospective review of mammographic findings. AJR Am J Roentgenol. 2000;174:535–8.PubMedGoogle Scholar
  8. 8.
    Tardivon AA, Viala J, Rudelli AC, Guinebretiere JM, Vanel D. Mammographic patterns of inflammatory breast carcinoma: a retrospective study of 92 cases. Eur J Radiol. 1997;24:124–30.PubMedCrossRefGoogle Scholar
  9. 9.
    Buzdar AU, et al. Effectiveness of mastectomy. Cancer. 1995;76:2286–2290.Google Scholar
  10. 10.
    Yang WT. Advances in imaging of inflammatory breast cancer. Cancer. 2010;116:2755–7.PubMedCrossRefGoogle Scholar
  11. 11.
    Lee KW, Chung SY, Yang I, et al. Inflammatory breast cancer imaging findings. J Clin Imaging. 2005;29:22–5.Google Scholar
  12. 12.
    Günhan-Bilgen I, Ustun EE, Memis A. Inflammatory breast carcinoma: mammographic, ultrasonographic, clinical, and pathologic findings in 142 cases. Radiology. 2002;223:829–38.PubMedCrossRefGoogle Scholar
  13. 13.
    Robertson FM, Bondy M, Yang W, et al. Inflammatory breast cancer. The disease, the biology, the treatment. CA Cancer J Clin. 2010;60:351–75.PubMedCrossRefGoogle Scholar
  14. 14.
    American College of Radiology (ACR). Illustrated breast imaging reporting and data system (BI-RADS). 3rd ed. Reston: American College of Radiology; 1998. p. 121–39.Google Scholar
  15. 15.
    Huong T, Le-Petross HT, Cristofanilli M, Carkaci S, Krishnamurthy S. MRI features of inflammatory breast cancer. AJR Am J Roentgenol. 2011;197(4):769–76.CrossRefGoogle Scholar
  16. 16.
    Sirishma Kalli S, Freer PE, Elizabeth A, Rafferty EA. 16 Lesions of the skin and superficial tissue at breast MR imaging. Radiographics. 2010;30:1891–913.PubMedCrossRefGoogle Scholar
  17. 17.
    Renz DM, Baltzer PAT, Böttcher J, Thaher F, Gajda M, Camara O, Runnebaum IB, Kaiser WA. Magnetic resonance imaging of inflammatory breast carcinoma and acute mastitis. A comparative study. Eur Radiol. 2008;18:2370–80.PubMedCrossRefGoogle Scholar
  18. 18.
    Le-Petross HT, Cristofanilli M, Carkaci S, Krishnamurthy S. MRI features of inflammatory breast cancer. AJR. 2011;197(4):769–76.CrossRefGoogle Scholar
  19. 19.
    Thukral A, Thomasson DM, Chow CK, Eulate R, Wedam SB. Inflammatory breast cancer: dynamic contrast-enhanced MR in patients receiving bevacizumab- initial experience 1. Radiology. 2007;244(3):727–35.PubMedCrossRefGoogle Scholar
  20. 20.
    Martincich L, Montemurro F, De Rosa G, Marra V, Ponzone R, Cirillo S, Gatti M. Monitoring response to primary chemotherapy in breast cancer using dynamic contrast-enhanced magnetic resonance imaging. Breast Cancer Res Treat. 2004;83:67–76.PubMedCrossRefGoogle Scholar
  21. 21.
    Muna M, Siema B, Bakheet M, et al. 18-Fluoro­deoxyglucose-positron emission tomography in inflammatory breast cancer. World J Surg. Société Internationale de Chirurgie. 2003;27(10):1099–104.Google Scholar
  22. 22.
    Robertson FM, Bondy M, et al. Inflammatory breast cancer. The disease, the biology, the treatment. CA Cancer J Clin. 2010;60:351–75.PubMedCrossRefGoogle Scholar
  23. 23.
    Alberini J-L, Lerebours L, et al. 18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) imaging in the staging and prognosis of inflammatory breast cancer. Cancer. 2009;115:5038–47.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag London 2013

Authors and Affiliations

  • Yolanda Villaseñor-Navarro
    • 1
  • Lesvia Olivia Aguilar-Cortazar
    • 1
  • Irma Perez-Zuñiga
    • 1
  • Roberto Alejandro Cruz-Morales
    • 1
  • Cecilia Magdalena Pavon-Hernandez
    • 1
  • Martha Patricia Perez-Badillo
    • 1
  • Jaime Ignacio Garcia-Gomez
    • 1
  1. 1.Department of RadiologyInstituto Nacional de Cancerologia-MexicoTlalpan, Mexico CityMexico

Personalised recommendations